Analysts Set AbCellera Biologics Inc. (NASDAQ:ABCL) Price Target at $15.83
Shares of AbCellera Biologics Inc. (NASDAQ:ABCL – Get Free Report) have been given a consensus recommendation of “Buy” by the seven brokerages that are covering the firm, MarketBeat reports. Seven investment analysts have rated the stock with a buy recommendation. The average 12-month target price among analysts that have issued ratings on the stock in […]
More Stories
Icon Wealth Advisors LLC Has $44,000 Holdings in The Coca-Cola Company (NYSE:KO)
Icon Wealth Advisors LLC decreased its stake in shares of The Coca-Cola Company (NYSE:KO – Free Report) by 96.2% during...
Icon Wealth Advisors LLC Sells 1,764 Shares of Fiserv, Inc. (NYSE:FI)
Icon Wealth Advisors LLC lessened its stake in Fiserv, Inc. (NYSE:FI – Free Report) by 88.5% in the 3rd quarter,...
Icon Wealth Advisors LLC Has $85,000 Holdings in iShares TIPS Bond ETF (NYSEARCA:TIP)
Icon Wealth Advisors LLC lowered its position in iShares TIPS Bond ETF (NYSEARCA:TIP – Free Report) by 91.9% in the...
Kewaunee Scientific (NASDAQ:KEQU) Cut to “Hold” at StockNews.com
StockNews.com downgraded shares of Kewaunee Scientific (NASDAQ:KEQU – Free Report) from a buy rating to a hold rating in a...
Insider Buying: Nine Energy Service, Inc. (NYSE:NINE) Major Shareholder Acquires $517,650.00 in Stock
Nine Energy Service, Inc. (NYSE:NINE – Get Free Report) major shareholder William Monroe purchased 435,000 shares of Nine Energy Service...
PC Connection, Inc. (NASDAQ:CNXN) Director Sells $350,000.00 in Stock
PC Connection, Inc. (NASDAQ:CNXN – Get Free Report) Director Negrini David Beffa sold 5,000 shares of the business’s stock in...